 NEWTOWN, Pa., Nov. 28, 2022 GLOBE NEWSWIRE -- Onconova Therapeutics, Inc. NASDAQ: ONTX, a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that it will participate in the RHK Capital Disruptive Growth Conference being held in the offices of Reed Smith in New York, NY on December 5-6, 2022. Mark Guerin, Chief Operating Officer Chief Financial Officer, will present a corporate overview at the conference on Tuesday, December 6th at 11:20 a.m. ET. 